Usz Remedium Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 30.00 K
- Company Age 6 Year, 10 Days
About Usz Remedium
Usz Remedium Private Limited (URPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 February 2019 (Six years 10 days old ). Its registered office is in Srinagar, Jammu & Kashmir, India.
The Company is engaged in the Manufacturing Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 30.00 K , as per Ministry of Corporate Affairs (MCA) records.
Usman Gani, Shafaat Siddiqi, and Zubair Dar serve as directors at the Company.
Company Details
-
Location
Srinagar, Jammu & Kashmir, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U36900JK2019PTC010819
-
Company No.
010819
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 Feb 2019
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Jammu
Industry
Who are the key members and board of directors at Usz Remedium?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Shafaat Siddiqi
![]() |
Managing Director | 04-Feb-2019 | Current |
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Zubair Dar
![]() |
Director | 04-Feb-2019 | Current |
Usman Gani
![]() |
Director | 04-Feb-2019 | Current |
Financial Performance of Usz Remedium.
Enhance accessibility to Usz Remedium's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
![Graph illustrating revenue growth over time](/Images/financial/revenue-growth.webp)
![Graph showing profit and loss trends over time](/Images/financial/profit-loss.webp)
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Usz Remedium?
Unlock access to Usz Remedium's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
![Shareholding Indicator graph](/Images/tcc-login/Shareholding-Indiacator-1200.webp)
Charges (Loans)
![Placeholder for charges-related data](/Images/tcc-no-data-images/Charges.webp)
There are no open charges registered against the company as per our records.
How Many Employees Work at Usz Remedium?
Unlock and access historical data on people associated with Usz Remedium, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
![Graph showing employee growth trends](/Images/tcc-login/Employee-Graph.webp)
Deals i
![Graph showing company valuation over time](/Images/tcc-login/Valuation-Graph-small.webp)
Gain comprehensive insights into the Deals and Valuation data of Usz Remedium, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Usz Remedium's trajectory.
Rating
![Graph displaying rating trends over time](/Images/tcc-login/Rating-Graph-small.webp)
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
![Alert Indicator](/Images/tcc-login/Alert-Indicator-small.webp)
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.